Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Abbott Diagnostics Scarborough Inc. currently manages 2 pending office actions within the Chemistry & Materials technology area. This prosecution activity is distributed across 2 distinct examiners and 2 distinct art units. The relationship between the 2 pending office actions and the 2 distinct examiners indicates a decentralized examination process where each matter is handled by a different individual. This distribution requires practitioners to tailor their arguments to the specific preferences of multiple officials rather than developing a unified strategy for a single examiner. The involvement of 2 distinct examiners ensures that each application receives an independent technical review.
The data identifies BOWERS, NATHAN ANDREW as the busiest examiner for this portfolio, currently responsible for 1 pending office action. Because this examiner handles a portion of the total pending actions, their specific tendencies in the Chemistry & Materials sector will influence the portfolio's immediate outcomes. The presence of 2 distinct art units further suggests that the underlying technologies may span different specialized classifications. Managing these 2 pending office actions across separate administrative units necessitates a broad understanding of procedural nuances across different sections of the patent office. Practitioners should monitor these 2 distinct art units for any variations in examination standards that could affect the Chemistry & Materials filings.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOWERS, NATHAN ANDREW | 1 | 59.5% | +31.7% |
| SWITZER, JULIET CAROLINE | 1 | 42.4% | +54.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18409552 | MICROFLUIDIC DEVICES AND RELATED METHODS | BOWERS, NATHAN ANDREW | 50d overdue |
| 16131580 | DETECTION OF RECOMBINASE POLYMERASE AMPLIFICATION USING DUAL-HAPTEN PROBE | SWITZER, JULIET CAROLINE | 9d |
| Art Unit | Apps |
|---|---|
| 1799 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18409552 | MICROFLUIDIC DEVICES AND RELATED METHODS | BOWERS, NATHAN ANDREW | 1799 | §103 | Final Rejection | 50d overdue | Pending | Jan 10, 2024 |
| 16131580 | DETECTION OF RECOMBINASE POLYMERASE AMPLIFICATION USING DUAL-HAPTEN PROBE | SWITZER, JULIET CAROLINE | 1682 | §112 | Final Rejection | 9d | Pending | Sep 14, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAbbott Diagnostics Scarborough Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Nathan Andrew Bowers has the most, with 1 of Abbott Diagnostics Scarborough Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
